FT LAUDERDALE, FL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Resurgence Biomedical Sciences Inc, founded in 2022, is a community nonprofit in the Medical Research sector that reported $1.4M in total revenue in fiscal year 2025. Revenue grew 12% year-over-year, indicating healthy expansion.
To conduct and support scientific research in the fields of biostasis resuscitation and reanimation medicine.
The organization completed three biostasis cases during 2025.
The organization sponsored a five-day educational conference focused on biostasis and the life extension sciences.
Other organizational activities included scientific research and education related to biostasis focusing primarily on hypothermic tissue stabilization for preservation purposes. The organization also...
Other organizational activities included scientific research and education related to biostasis focusing primarily on hypothermic tissue stabilization for preservation purposes. The organization also provided education and training services for medical professionals and delivered scientific presentations at public conferences.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $1,432,171 | $1,275,000 | +0.1% |
| Expenses | $1,468,837 | $1,194,083 | +0.2% |
| Net Income | $-36,666 | $80,917 | -1.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Christine Gaspar | Technical Writer | 40.00 |
Highest
|
$111,725 | $17,543 | $129,268 |
| Houston Westfall | President and CEO | 40.00 |
Officer
|
$66,488 | $3,357 | $69,845 |
| Benjamin Best | Director | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| Chase Falcon | Director | 4.00 |
Director
|
$0 | $0 | $0 |
| Arthur Zahreciyan | Director | 4.00 |
Director
|
$0 | $0 | $0 |
| Victoria Ilina | Administrator | 40.00 |
Highest
|
$108,152 | $15,076 | $123,228 |
| Carrie Radomski | Director | 4.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $1,432,171 | $1,468,837 | $510,633 | $-36,666 |
| 2024 | $1,275,000 | $1,194,083 | $547,299 | $80,917 |
| 2023 | $500,000 | $496,193 | $163,575 | $3,807 |
| 2022 | $100,000 | $40,232 | $259,768 | $59,768 |
Compare Resurgence Biomedical Sciences Inc with other nonprofits in Florida and across the country.